Sei sulla pagina 1di 17

SHRI BARATHI.

NAME

REG.NO

14BBR050

CLASS

III BBA (RETAIL MANAGEMENT)

SUBJECT

ENTREPRENEURIAL
DEVELOPMENT

TOPIC

SUCCESSFUL WOMEN
ENTREPRENEURS IN INDIA

KIRAN MAZUMDAR

Kiran

Mazumdar-Shaw (born

23

March

1953, Bangalore,

India)

is

an Indian entrepreneur. She is the chairman and managing director of Biocon Limited, a
biotechnology company based in Bangalore (Bengaluru), India and the current chairperson of
IIM-Bangalore. In 2014, she was awarded the Othmer Gold Medal, for outstanding contributions
to the progress of science and chemistry.She is on the Financial Times top 50 women in
business list. As of 2015, she was listed as the 85th most powerful woman in the world
by Forbes.At present in 2016, she has been listed one more time in "Forbes" - the most powerful
woman in the world at 77th position.

EARLY LIFE AND EDUCATION


Kiran Mazumdar was born to Gujarati parents in Bangalore, India. She went to school at
Bangalores Bishop Cotton Girl's High School, graduating in 1968. She then attended Mount
Carmel College, Bangalore, a women's college offering pre-university courses as an affiliate of
Bangalore University. She studied biology and zoology, graduating from Bangalore

University with a B.Sc. in Zoology in 1973.Mazumdar hoped to go to medical school, but did not
obtain a scholarship.
Her father, Rasendra Mazumdar, was the head brewmaster at United Breweries. He
suggested that Kiran study fermentation science, and trains to be a brewmaster, a very
nontraditional field for a woman. Mazumdar went to Federation University (Formerly known as
University of Ballarat) in Australia to study Malting and Brewing. In 1974 she was the only
woman enrolled in the brewing course, and the top of her class. She earned the degree of Master
Brewer in 1975.
She worked as a trainee brewer in Carlton and United Breweries, Melbourne and as a
trainee maltster at Barrett Brothers and Burston, Australia. She also worked for some time as a
technical consultant at Jupiter Breweries Limited, Calcutta and as a technical manager at
Standard Maltings Corporation, Baroda between 1975 and 1977. However, when she
investigated the possibility of further work in Bangalore or Delhi, she was told that she would
not be hired as a master brewer in India because "It's a man's work."She began to look abroad,
and was offered a position in Scotland.

BIOCON
Before Kiran could move, she met Leslie Auchincloss, founder of Biocon Biochemicals
Limited, of Cork, Ireland. Auchincloss's company produced enzymes for use in the brewing,
food-packaging and textile industries. Auchincloss was looking for an Indian entrepreneur to
help establish an Indian subsidiary. Mazumdar agreed to undertake the job on the condition that
if she did not wish to continue after six months she would be guaranteed a brewmaster's position
comparable to the one she was giving up.

BEGINNING WITH ENZYMES


After a brief period as a Trainee Manager at Biocon Biochemicals Limited, of Cork,
Ireland, to learn more about the business, Kiran Mazumdar Shaw returned to India. She started
Biocon India in 1978 in the garage of her rented house in Bengaluru with a seed capital of Rs.

10,000. Although it was a joint venture, Indian laws restricted foreign ownership to 30% of the
company. The remaining 70% belonged to Kiran Mazumdar
The company's initial projects were the extraction of papain (an enzyme from papaya used to
tenderize meat) and isinglass (obtained from tropical catfish and used to clarify beer).Within a
year of its inception, Biocon India was able to manufacture enzymes and to export them to the
United States and Europe, the first Indian company to do so. At the end of her first year, Kiran
Mazumdar Shaw used her earnings to buy a 20-acre property, dreaming of future expansion.

EXPANDING INTO BIOPHARMACEUTICALS


Mazumdar-Shaw spearheaded Biocon's evolution from an industrial enzymes
manufacturing company to a fully integrated bio-pharmaceutical company with a well-balanced
business portfolio of products and a research focus on diabetes, oncology and auto-immune
diseases. She also established two subsidiaries: Syngene (1994) which provides early research
and development support services on a contract basis and Clinigene (2000) which focuses on
clinical research trials and the development of both generic and new medicines.Clinigene were
later merged with Syngene. Syngene was listed on BSE/NSE in 2015 and has a current market
cap of US$1.15 billion.
Mazumdar-Shaw is responsible for establishing Biocon's direction. As early as 1984, she
began to develop a research and development team at Biocon, focusing on discovery of novel
enzymes and on development of novel techniques for solid substrate fermentation
technology. The

company's

first

major

expansion

came

in

1987,

when Narayanan

Vague of ICICI Ventures (Industrial Credit and Investment Corporation of India) supported
creation of a venture capital fund of US$250,000. The money enabled Biocon to expand its
research and development efforts. They built a new plant featuring proprietary solid substrate
fermentation technology based on a semi-automated tray culture process, inspired by Japanese
techniques. In 1989, Biocon became the first Indian biotech company to receive US funding for
proprietary technologies.
In 1990, Kiran Maunder incorporated Biocon Biopharmaceuticals Private Limited
(BBLP) to manufacture and market a select range of biotherapeutics in a joint venture with the
Cuban Center of Molecular Immunology.

ESTABLISHING INDEPENDENCE
Beacon Biochemicals of Ireland was acquired from Leslie Auchincloss by Unilever in
1989. The partnership with Unilever helped Biocon to establish global best practices and quality
systems. In 1997, Unilever sold its specialty chemicals division, including Biocon, to Imperial
Chemical Industries (ICI). In 1998, Kiran Mazumdar's fianc, Scotsman John Shaw, personally
raised $2 million to purchase the outstanding Biocon shares from ICI. The couple married in
1998, whereupon she became known as Kiran Mazumdar-Shaw. John Shaw left his position as
chairman at Madura Coats to join Biocon. He became Biocons vice chairman in 2001.
In 2004, after seeking the advice of Narayan Murthy, Kiran Mazumdar-Shaw decided to
list Biocon on the stock market. Her intent was to raise capital to further develop Biocon's
research programs. Biocon was the first biotechnology company in India to issue an
IPO. Biocon's IPO was oversubscribed 33 times and its first day at the bourses closed with a
market value of $1.11 billion, making Biocon only the second Indian company to cross the $1billion mark on the first day of listing.

AFFORDABLE INNOVATION
Mazumdar-Shaw's belief in "affordable innovation" has been a driving philosophy behind
Biocon's expansion. Inspired by the need for affordable drugs in less-wealthy countries, she has
looked for opportunities to develop cost-effective techniques and lower-cost alternatives.She has
also proposed that drug companies be cost-sensitive in marketing to developing countries, so that
people can afford the drugs they need, particularly chronic therapies.
Mazumdar-Shaw noticed the market potential for statins (cholesterol fighting drugs) early
on. When the patent of the cholesterol-lowering drug lovastatin expired in 2001, Biocon got
involved in its development. Then they expanded to other forms of statins. Part of her strategy
was to enter into long-term supply contracts, establishing a dependable market base over time.
Statins soon accounted for over 50 per cent of the company's revenue. The companys revenue
went up from Rs. 70 core in 1998, to Rs. 500 crore in 2004 when it went public.

Biocon continues to expand into new areas. Yeast expression platforms offer a desirable
alternative to mammalian cell cultures for the genetic manipulation of cells for use in a variety of
drug treatments. Unicellular methylotrophic yeasts such as Pichia pastoris are used in the
production

of vaccines, antibody

fragments, hormones, cytokines,

matrix

proteins,

and biosimilars.
Biocon's major areas of research now include cancer, diabetes, and other auto-immune
diseases such as rheumatoid arthritis and psoriasis. Because of the high percentage of people in
India who chew betel or tobacco, India accounts for eighty-six per cent of oral cancer in the
world, known locally as "cancer cheek". Diabetes is prevalent, and people who do not wear
shoes are at risk to have a minor scrape or injury develop into gangrene, or "diabetes
foot". Biocon is also working on drugs to treat psoriasis, a skin pigment disease which can result
in social ostracization.
Bio-pharmaceuticals developed include Pichia-derived recombinant human insulin and
insulin analogs for diabetes, an Anti-EGFR monoclonal antibody for head and neck cancer, and
a biologic for psoriasis. Biocon is Asia's largest insulin producer, and has the largest perfusionbased antibody production facilities.
As of 2014, Biocon directed about 10% of its revenue back into research and
development, a much higher proportion than most Indian pharmacological companies. Biocon
has filed at least 950 patent applications as a result of its research activity. Mazumdar-Shaw has
actively engaged in acquisitions, partnerships and in-licensing within the pharmaceuticals and
bio-pharmaceutical area, entering into more than 2,200 high-value R&D licensing and other
deals between 2005 and 2010.

PHILANTHROPIC ACTIVITIES
In 2004, Kiran Mazumdar-Shaw started a corporate social responsibility wing at Biocon,
the Biocon Foundation. The Foundation focuses on the areas of health, education and
infrastructure, especially in rural areas of Karnataka which lack healthcare facilities.

Mazumdar-Shaw dislikes the term "philanthropy", believing that it often provides


temporary fixes rather than changing underlying conditions.

She prefers the term

"compassionate capitalist", believing that properly applied business models can provide an
ongoing foundation for sustainable social progress. "Innovation and commerce are as powerful
tools for creating social progress as they are for driving technological advancement... when they
are put to use for social progress, the implementation is a lot cheaper, a lot more people benefit,
and the effect is more lasting. In 2015, she joined The Giving Pledge, promising that at least half
of her wealth will be dedicated to philanthropy.

HEALTH
India does not have organized health care programs such as socialised medicine or
government-backed health insurance. Rural areas may have only one doctor for every two
thousand people: it is estimated that 70 million people do not have the money to pay for a
doctor's visit or for medicine.The Biocon Foundation is involved in numerous health and
education outreach programs to benefit the economically weaker sections of Indian society.

AROGYA RAKSHA YOJANA


With Dr. Devi Shetty of Narayana Hrudayalaya Hospital, Mazumdar-Shaw has supported
the development of Arogya Raksha Yojana (Disease Protection Program/Health Help).Through
this program Biocon Foundation establishes clinics to offer clinical care, generic medicines and
basic tests for those who cannot afford them. As of 2010, seven clinics each served a population
of 50,000 patients living within a radius of 10 km, treating in total more than 300,000 people per
year. Clinics organize regular general health checks in remote villages by bringing in physicians
and doctors from network hospitals. To improve early detection of cancer, they have trained
young women as community health workers, using smart phones to send photographs of
suspicious lesions to oncologists at the cancer center. Public health campaigns such as "Queen of
Heart" educate people about specific health issues and promote early detection of problems such
as cardiovascular disease.
The clinics operate on a model of micro-financed health insurance. Biocon provides lowcost drugs, making a negligible profit on a unit basis, but an overall profit on volume due to the
participation of large numbers of people. Clinics also use a "subsidised convenience" pricing

plan, under which more wealthy patrons pay full price in return for the convenience of
scheduling their visits and procedures at desirable times, while poorer patients can obtain cheap
or even free services by choosing less desirable times.Doctors and researchers look for
opportunities to use cutting-edge technology in ways that will drive down costs and ensure
quality of service.

MAZUMDAR-SHAW MEDICAL FOUNDATION


The death of her best friend, Nilima Rovshen, and the illnesses of her husband and her
mother from cancer, have motivated Kiran Mazumdar-Shaw to strongly support cancer research
and treatment. In 2009, she established a 1,400-bed cancer care center, the Mazumdar-Shaw
Medical Foundation, at the Narayana Health City campus in Bangalore, collaborating with Dr.
Devi Shetty of Narayana Hrudayalaya. In 2011, she added a center for advanced therapeutics
with a bone marrow transplant unit and a research center.[50] Her goal is to create a world-class
cancer center.
Mazumdar Shaw Medical Foundation is a non-profitable organization and has two arms
to support its cause, which are Mazumdar Shaw Center for Translational Research and
Mazumdar Shaw Cancer outreach program. Mazumdar Shaw Medical Foundation is set to
improve the health of the community by setting a standard of excellence in research and
community outreach programs. MSMF pushes the boundaries of discovery, transforms
healthcare and creates hope for humanity. MSMF will deliver the promise of good health
through breakthrough research, treatment innovation, and philanthropy. MSMF employs worldclass researchers who develop and test the effectiveness of new cancer therapies. This unique
bench-to-bedside approach to cancer research and patient care can only be found in a
distinguished center, Mazumdar Shaw Medical Foundation.

EDUCATION
In collaboration with Mcmillan India Limited and teacher Prathima Rao, MazumdarShaw has supported development and use of a basic mathematics textbook, introduced in
Kannada schools in 2006.

She funded a multi-year research program by creating the Bioco Cell for Innovation
Management with Dr. Prasad Kaipa at the Indian School of Business in 2009.

INFRASTRUCTURE
Mazumdar-Shaw

speaks

openly

about

the

importance

of

improving

India's

infrastructure, emphasizing the need to address issues such as efficient governance, job creation,
and food, water, and health insecurity.
In Bangalore itself, Biocon, Infosys and other companies have had a significant impact
on the city. These companies attract many scientists who would otherwise go overseas. Once a
"pensioner's paradise", Bangalore is now called "the best urban working environment in
India".Biocon Park, built in 2005 not far from Mazumdar-Shaw's original office, is a ninety-acre
campus with five thousand employees. Outside the developed areas, however, there is still
severe poverty
Mazumdar-Shaw is an energetic proponent of good government and infrastructure. She
supported the Bangalore Agenda Task Force, an initiative of S. M. Krishna and Nandan
Nilekani to improve the city's infrastructure and standard of living. Mazumdar-Shaw is part of
the Bangalore City Connect Foundation, a non-profit trust for discussion of civic issues,
involving both urban stakeholders and the government. Mazumdar-Shaw is actively engaged in
urban reform, partnering with Jana Urban Space Foundation and local government to improve
roads. She is also involved in the Bangalore Political Action Committee (BPAC), which reviews
and recommends candidates running in elections.
After the 2009 flood, Biocon, Infosys and Wipro all committed to rebuilding homes for
flood victims in north Karnataka. Biocon committed to building 3,000 houses at a cost of Rs 30
crore.

BOARD MEMBERSHIPS
Mazumdar-Shaw is a member of the board of governors of the prestigious Indian School
of Business and a past member of the Board of Governors of the Indian Institute of Technology
Hyderabad

Dr Kiran Mazumdar-Shaw, Chairperson, Board of Governors, IIMB, with Shah Rukh Khan
during IIMBUE 2015 on Dec 11
As of February 2014, Kiran Mazumdar-Shaw became the first woman to head the Board
of Governors of the Indian Institute of Management Bangalore (IIMB).

AWARDS AND HONOURS

Kiran Mazumdar-Shaw with the Othmer Gold Medal, 2014


As of 2010, Kiran Mazumdar-Shaw was named among TIME magazines 100 most
influential people in the world. She is on the 2011 Financial Times top 50 women in business
list. As of 2014, she was listed as the 92nd most powerful woman in the world by Forbes. In

2015, she had risen to 85th in the Forbes ranking. The risk taking Women Entrepreneur was
voted as Global Indian of the Year by Pharma Leaders Magazine in 2012.

INTERNATIONAL AWARDS
Mazumdar-Shaw is the recipient of several prestigious international awards including
the Othmer Gold Medal (2014) for outstanding contributions to the progress of science and
chemistry, the Nikkei Asia Prize (2009) for Regional Growth, the Veuve Clicquot Initiative For
Economic Development For Asia' Award (2007), Ernst & Young Entrepreneur of the Year
Award for Life Sciences & Healthcare (2002)and 'Technology Pioneer' recognition by World
Economic Forum (2002). On 05/05/2015 Federation University Australia (Formerly known as
University of Ballarat) named a road in Mt Helen campus as Mazumdar Drive . Kiran and Shaw
together attended the opening function and cut the rippon.

INDIAN AWARDS
Her pioneering work in the biotechnology sector has earned her numerous national
awards, including the prestigious Padma Shri (1989) and the Padma Bhushan (2005) from the
government of India. She was given the Economic Times Award for 'Businesswoman of the
Year' in 2004. At the Pharmaleaders Pharmaceutical Leadership Summit she was named "Global
Indian Woman of the Year" (2012); she also received the Express Pharmaceutical Leadership
Summit Award for "Dynamic Entrepreneur" in 2009. The Indian Merchants' Chamber Diamond
Jubilee Endowment Trust's Eminent Businessperson of the Year Award was presented to Kiran
Mazumdar-Shaw in 2006 by the Governor of Maharashtra, S. M. Krishna. She also has received
the Indian Chamber of Commerce Lifetime Achievement Award (2005), the 'Corporate
Leadership Award' by the American India Foundation (2005). and the Karnataka Rajyotsava
Award (2002).

HONORARY DEGREES
Mazumdar-Shaw received an honorary Doctorate of Science in 2004, from her alma
mater, Ballarat University, in recognition of her contributions to biotechnology. She has also
been

awarded

honorary

doctorates

from

the University

of

Abertay,

Dundee,

UK

(2007) the University of Glasgow, UK (2008), Heriot-Watt University, Edinburgh, UK (2008)


and University

College

Cork,

Ireland

(2012). She

received

an

honorary

doctorate

from Davangere University, India, at its first convocation, 27 July 2013, in recognition of her
contribution in the field of Biotechnology.
When you talk of women entrepreneurs, there are only a handful of them in our country.
The recent wave of new change that our country is overseeing, this phenomenon is changing.
Suchi Mukherjee, a women entrepreneur who has been constantly proving with her achievements
that it is completely not a gender based space where a few years ago only males dominated. Who
is Suchi Mukherjee? You must be wondering. Suchi Mukherjee is the founder of Limeroad
website, which lets you discover, share and shop women lifestyle products. Suchi Mukherjee
wiki will further tell you about her journey throughout her life, her struggles, her career, and
other interesting facts about Suchi Mukherjee.

SUCHI MUKHERJEE

When you talk of women entrepreneurs, there are only a handful of them in our country.
The recent wave of new change that our country is overseeing, this phenomenon is changing.
Suchi Mukherjee, a women entrepreneur who has been constantly proving with her achievements
that it is completely not a gender based space where a few years ago only males dominated. Who
is Suchi Mukherjee? You must be wondering. Suchi Mukherjee is the founder of LimeRoad
website, which lets you discover, share and shop women lifestyle products. Suchi Mukherjee
wiki will further tell you about her journey throughout her life, her struggles, her career, and
other interesting facts about Suchi Mukherjee.

SUCHI MUKHERJEE BIRTH


Suchi Mukherjee date of birth is a little unclear but she was born in the year 1973 and
was 39 year old when she founded her famous fashion portal for women I.e. Limeroad.com.
From a young age, she has been involved in scaling up many businesses and starting some on her
own, which is quite ambitious for a person like her. Suchi Mukherjee birthday has always been a
sumptuous affair among her elite friends and family.

SUCHI MUKHERJEE FAMILY BACKGROUND


Suchi Mukherjee belongs to a middle class family from Haryana. Since she had been
married and went on to work at some of the great companies we know, even founding her own, it
has been a dream life for her. Suchi Mukherjee family now consists of her husband, two kids and
herself. Her parents must have played a huge role in her success, and so must her husband, Suchi
Mukherjee family have contributed highly in what she is today.

SUCHI MUKHERJEE EDUCATION


Suchi Mukherjee has sought education from the famed University of Cambridge and
London School of Economics. Suchi Mukherjee completed her bachelor in arts specializing in
economics and mathematics from the University of Cambridge. She has learned all the trades of
business by doing her masters in economics and finance from one of the most prestige business
schools in the world which is London School of Economics. The biography of Suchi Mukherjee
details more of her personal as well as professional life, keep reading.

SUCHI MUKHERJEE PERSONAL LIFE


For a business woman like Suchi Mukherjee, her work life and personal life is hard to
differentiate. She tries to give enough time to her family as well as friends even in her ultra busy
startup life. Suchi Mukherjee net worth is not disclosed in the media however it must be quite
high considering her stature as a founder of a successful startup and previous employee in some
of the best companies in the world. Suchi Mukherjee contact details are the ones given on the
LimeRoad website as well as in her LinkedIn profile, you can mail her. Suchi Mukherjee
biography further shows how she went on from working in various companies to founding one
on her own.

SUCHI MUKHERJEE CAREER


With such a brilliant portfolio of companies under her belt, Suchi Mukherjee
success story might seem as if everything happened overnight without any struggle.
The reality is completely different; she too had to face ups and downs throughout her
professional life. At first being a part of newly formed companies to scale them up
and making them global and starting a company of her own which has become highly
successful is no easy job. After completing her bachelors and masters degree from
University of Cambridge and London School of economics respectively, she soon
started working as a professional right after completing her studies.
She started working at Lehman Brothers Inc. in 1998 in a position of Senior Associate for
Corporate Finance. It was Suchi Mukherjee first job in her career. She worked there for 5 years
until moving on to her next company in her career. She focused highly on Telecoms Media
technology and Financial Institutions while she worked there. After leaving the company with a
rich experience, she moved on to work with Virgin Media from June 2003 as a Director of
Change and Business Development. Also, she was highly consumer focused in Virgin Media and
was a member of Consumer Division Management Team.
She worked with Virgin media for 2 whole years and then switched over her career path
again to eBay, which was one of the best e-commerce platforms available. With eBay, she learnt

many skills that would later be handy in her own venture. Also this change in companies helped
her work in diversified conditions across many companies. In the year 2006, Skype was a part of
eBay then, which is now property of Microsoft. With the phenomenal work she did, Suchi
Mukherjee was soon promoted to Director and Member of Executive Management Team of
Skype. She oversaw the major overhaul that Skype went through in its earlier stage and made it
what it is now. There were structural concerns over the company as 3 CEOs were changed in
mere 2 years.
After empowering Skype with her skills, she was again promoted to a position of
Managing Director of Gumtree, which was a child company of eBay Inc. After all this years, she
had become reliant enough to start something on her own and take it off. She took Gumtree to
great heights and made it a market leader in UK. After successfully handling companies of this
scale, she set out to do something of her own and founded LimeRoad, which is her own venture.
She is also the CEO of LimeRoad website. It has received various rounds of funding and can
sustain the business as it is now which is highly commendable as very few startups become
successful.

INTERESTING FACTS ABOUT SUCHI MUKHERJEE


1. She lifted the company Gumtree from No.3 to No.1 in a matter of few years.
2. She started her working career at a young age of 22 in Lehman Brothers Inc.
3. She was one of the most promoted people in eBay Inc because of her brilliant managerial
and business skills.

SUCHI MUKHERJEE LOVE LIFE


Is Suchi Mukherjee Married? Yes, she is. Though there is not much information about
Suchi Mukherjee husband but she is happily married having her own family. Talking about
Suchi Mukherjee children, she has two kids. Suchi Mukherjee dating someone was all false news
as we never came to know about Suchi Mukherjee boyfriend. She has been happily married from

a past few years and living in Haryana with her family. This was all about the life of Suchi
Mukherjee. Explore the next biography of Singer Ankit Tiwari.

INDU JAIN

Indu

Jain belongs

to

the Sahu

Jain

family and

is

the

current

chairperson

of India's largest media group, Bennett, Coleman & Co. Ltd., which owns the Times of India and
other large newspapers. She is widowed with two sons.
According to Forbes 2015 rankings, Indu Jain had a net worth of $3.1 billion and was ranked
57th-richest person in India and 549th-richest person in the world.

PROFESSIONAL
Indu Jain is Chairperson of The Times Group. In her capacity as Chairperson of The
Times Group, Indu has since infused new energy into the growth of India's largest media house.
The Times Foundation, which she founded and carefully guides, has garnered
international acclaim for its, often pioneering, activities in the field of development. A humanist
to the core, under her direction, The Times Foundation runs Community Services, Research
Foundation and Times Relief Fund for disaster reliefs like floods, cyclones, earthquakes and

epidemics. Indu's championing of women's causes is also well known. She actively supports
women's rights and the encouragement of entrepreneurship.
Indu Jain is also founder President of the Ladies wing of FICCI A patron of literature
and culture, she is Chairperson of the Bharatiya Jnanpith Trust, which awards India's most
prestigious and highest literary award, the Jnanpith award and supports endeavors in the field of
literature in every major Indian language.
She addressed the United Nations in 2000 at the Millennium World Peace Summit of
Religious and Spiritual Leaders, a speech in which she stressed the need for oneness among
faiths and went on to chair a special session of the conference.
A successful business magnate, she is also often confused with the other Indu Jain who is
an accomplished Hindi author and poet. Among the other Indu Jain's compositions, her noted
compositions, she has penned the lyrics of critically acclaimed movies like Chashme Baddoor,
Sparsh and Katha. Earlier, she had also conducted interviews and talk shows for Doordarshan.
Spreading the message of Peace Within First, Indu Jain spearheads a movement to spread
the principles of peace globally.

AWARDS
Ms Jain was awarded the Padma Bhushan by the Government Of India in January 2016
.She is also the guiding force behind The Oneness Forum, formally launched by the President of
India in 2003. The Forum recently awarded the Mahatma-Mahavira Awards to outstanding
individuals from all of walks of life and is involved in several activities that seek to bring, and
highlight, a sense of Oneness in the world.

PERSONAL
Indu Jain was married to Ashok Kumar Jain by whom she had two sons, Samir
Jain, Vineet Jain and a daughter. Her husband died on February 4, 1999 in Cleveland, United
States at age of 65, following a heart transplant on January 10.

Potrebbero piacerti anche